Frost Radar™: North American Clinical Documentation Improvement Market, 2022

Healthcare Frost Radar™: North American Clinical Documentation Improvement Market, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

INDUSTRY
Healthcare

RELEASE DATE
25-Mar-2022
REGION
North America
DELIVERABLE TYPE
Frost Radar

RESEARCH CODE
K72F-01-00-00-00
SKU
HC03522-NA-MR_26397
Yes
SHARE

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC03522-NA-MR_26397

Frost Radar™: North American Clinical Documentation Improvement Market, 2022
Published on: 25-Mar-2022 | SKU: HC03522-NA-MR_26397

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

Clinical documentation improvement (CDI), a vital mechanism in documenting care in the healthcare space, is a strategic necessity that goes beyond a component in the broader revenue cycle management (RCM) of claims processing. It focuses on improved patient outcomes, supports data quality that tells an accurate story of the patient’s care, facilitates accurate reimbursement, and ensures compliance risk management and revenue integrity. With growing automation and digitalization in the healthcare space, legacy CDI solution providers are not able to evolve with payers’ ever-changing regulatory requirements for clinical documentation and coding.

Solution providers are reimagining tools that pave the way for next-generation clinical documentation across the healthcare continuum. The emphasis on detailed clinical documentation and coding will be paramount to personalized treatments, preventing adverse effects (medical reconciliation, hospital-acquired infections, clinical trial mismatches) and optimizing the clean claims rate. As a result, the contribution of various CDI solutions to the overarching RCM portfolio is forecast to increase from 20% in 2020 to 33% in 2024. Regulators prioritize digitally-enabled clinical documentation as they move away from legacy approaches of assessing gaps in payment cycles (clinical documentation after treatment) and aim for transparency, accuracy, and specificity of fund utilization in annual budgets and push for more proactive population health management and prioritized disease-specific CDI. There is a clear need for automation and analytics-based CDI management solutions that leverage the power of machine learning (ML) and artificial intelligence (AI) to achieve regulatory compliance, virtual assistant technology, natural language processing, clinical decision support, and assist with timely decision-making for proper reimbursement and reduce physician burnout.

The overall goal of any CDI program is to improve clinical documentation, coding, and reimbursement. It also aims to provide completeness, consistency, and accuracy of medical records that support the physician’s judgment and medical decision making. Over the next 3 to 5 years, the CDI market is expected to witness major consolidation as merger and acquisition (M&A) activities increase among legacy EMR companies, CDI vendors, and legacy HIT vendors competing to provide pure-play solutions and capabilities on a centralized platform. The role of CDI in enabling healthcare equity will be paramount. Accurate, comprehensive, and ethnic-appropriate clinical documentation will help providers standardize reimbursement and opt for payment exceptions for specific population health management initiatives.

This will allow equitable access to quality care for all. The impact of potential regulations centered around chronic condition management (e.g., COVID-19) focused on post-pandemic care, telemedicine, and virtual care will boost CDI growth further. Integrating CDI EMR workflow tools will help vendors offer more advanced CDI and best-in-class offerings and capabilities. Outsourcing CDI skills, training, and expertise will likely continue to rise, resulting in suboptimal outcomes and staff shortages.

Author: Koustav Chatterjee

Strategic Imperative

Strategic Imperative (continued)

Growth Environment

North American CDI Market—Key Competitors

Frost Radar™: Clinical Documentation Improvement

Frost Radar™: Competitive Environment

3M Health Information Systems

Arintra

Cerner

Chartwise

EZDI (an AGS Health company)

Greenway Health

Nuance (part of Microsoft)

Optum

R1 RCM

Waystar

Strategic Insights

Significance of Being on the Frost Radar™

Frost Radar™ Empowers the CEO’s Growth Team

Frost Radar™ Empowers Investors

Frost Radar™ Empowers Customers

Frost Radar™ Empowers the Board of Directors

Frost Radar™: Benchmarking Future Growth Potential

Frost Radar™: Benchmarking Future Growth Potential

Legal Disclaimer

Frost Radar™: Benchmarking Future Growth Potential 2 Major Indices, 10 Analytical Ingredients, 1 Platform

Growth Index

Growth Index (GI) is a measure of a company’s growth performance and track record, along with its ability to develop and execute a fully aligned growth strategy and vision; a robust growth pipeline system; and effective market, competitor, and end-user focused sales and marketing strategies.

  • Market Share (previous 3 years)
    This is a comparison of a company’s market share relative to its competitors in a given market space for the previous 3 years.
  • Revenue Growth (previous 3 years)
    This is a look at a company’s revenue growth rate for the previous 3 years in the market/industry/category that forms the context for the given Frost Radar™.
  • Growth Pipeline
    This is an evaluation of the strength and leverage of a company’s growth pipeline system to continuously capture, analyze, and prioritize its universe of growth opportunities.
  • Vision and Strategy
    This is an assessment of how well a company’s growth strategy is aligned with its vision. Are the investments that a company is making in new products and markets consistent with the stated vision?
  • Sales and Marketing
    This is a measure of the effectiveness of a company’s sales and marketing efforts in helping it drive demand and achieve its growth objectives.

Innovation Index

Innovation Index (II) is a measure of a company’s ability to develop products/ services/ solutions (with a clear understanding of disruptive Mega Trends) that are globally applicable, are able to evolve and expand to serve multiple markets and are aligned to customers’ changing needs.

  • INNOVATION SCALABILITY
    This determines whether an organization’s innovations are globally scalable and applicable in both developing and mature markets, and also in adjacent and non-adjacent industry verticals.
  • RESEARCH AND DEVELOPMENT
    This is a measure of the efficacy of a company’s R&D strategy, as determined by the size of its R&D investment and how it feeds the innovation pipeline.
  • PRODUCT PORTFOLIO
    This is a measure of a company’s product portfolio, focusing on the relative contribution of new products to its annual revenue.
  • MEGATRENDS LEVERAGE
    This is an assessment of a company’s proactive leverage of evolving, long-term opportunities and new business models, as the foundation of its innovation pipeline.
  • CUSTOMER ALIGNMENT
    This evaluates the applicability of a company’s products/services/solutions to current and potential customers, as well as how its innovation strategy is influenced by evolving customer needs.

Significance of Being on the Frost Radar™

Companies plotted on the Frost RadarTM are the leaders in the industry for growth, innovation, or both. They are instrumental in advancing the industry into the future.

  • GROWTH POTENTIAL
    Your organization has significant future growth potential, which makes it a Company to Action.
  • BEST PRACTICES
    Your organization is well positioned to shape Growth Pipeline™ best practices in your industry.
  • COMPETITIVE INTENSITY
    Your organization is one of the key drivers of competitive intensity in the growth environment.
  • CUSTOMER VALUE
    Your organization has demonstrated the ability to significantly enhance its customer value proposition.
  • PARTNER POTENTIAL
    Your organization is top of mind for customers, investors, value chain partners, and future talent as a significant value provider.

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Digital Health research

06 Aug 2026   |   Global   |   Technology Research

Decentralized Clinical Trials Powered by Blockchain and Digital Twins

This report examines how decentralized clinical trials (DCTs), enabled by blockchain, digital twins, and artificial intelligence, are reshaping global clinical research. It traces the shift from site-centric to patient-centric models and quantifies the growing scale, globalization, and complexity of...

30 Jul 2026   |   Global   |   Frost Radar

Frost Radar™: Life Sciences Regulatory Information Management Platforms, 2026

The regulatory technology market in life sciences has, over the last five years, quietly transformed from a back-office category dominated by document repositories and submission publishing tools to one of the most consequential software segments serving the pharmaceutical, biotech, and medical devi...

22 Jul 2026   |   Global   |   Market Research

Healthcare Cybersecurity, Global, 2026–2031

The global healthcare cybersecurity market is entering a new phase of growth as cyber risk becomes directly linked to patient safety, care continuity, and operational resilience. Healthcare organizations are expanding digital infrastructure across cloud environments, connected medical devices, patie...

17 Jul 2026   |   Global   |   Technology Research

Innovations and Growth Opportunities in AI-Driven Drug Discovery, Precision Diagnostics, Advanced Biologics, and Next-generation Vaccines

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping drug discovery, diagnostics, and therapeutic delivery across oncology, infectious diseases, rare and autoimmune disorders, metabolic and age...

15 Jul 2026   |   North America   |   Frost Radar

Frost Radar™: Clinical Ambient AI in North America, 2026

This Frost Radar™ analyzes the clinical ambient AI solutions that enable clinicians to improve their efficiency at the point of care. AI scribe capability has become the baseline market requirement, eliminating it as a differentiator and pushing vendors to compete on higher-order clinical and fina...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

Clinical documentation improvement (CDI), a vital mechanism in documenting care in the healthcare space, is a strategic necessity that goes beyond a component in the broader revenue cycle management (RCM) of claims processing. It focuses on improved patient outcomes, supports data quality that tells an accurate story of the patient’s care, facilitates accurate reimbursement, and ensures compliance risk management and revenue integrity. With growing automation and digitalization in the healthcare space, legacy CDI solution providers are not able to evolve with payers’ ever-changing regulatory requirements for clinical documentation and coding. Solution providers are reimagining tools that pave the way for next-generation clinical documentation across the healthcare continuum. The emphasis on detailed clinical documentation and coding will be paramount to personalized treatments, preventing adverse effects (medical reconciliation, hospital-acquired infections, clinical trial mismatches) and optimizing the clean claims rate. As a result, the contribution of various CDI solutions to the overarching RCM portfolio is forecast to increase from 20% in 2020 to 33% in 2024. Regulators prioritize digitally-enabled clinical documentation as they move away from legacy approaches of assessing gaps in payment cycles (clinical documentation after treatment) and aim for transparency, accuracy, and specificity of fund utilization in annual budgets and push for more proactive population health management and prioritized disease-specific CDI. There is a clear need for automation and analytics-based CDI management solutions that leverage the power of machine learning (ML) and artificial intelligence (AI) to achieve regulatory compliance, virtual assistant technology, natural language processing, clinical decision support, and assist with timely decision-making for proper reimbursement and reduce physician burnout. The overall goal of any CDI program is to improve clinical documentation, coding, and reimbursement. It also aims to provide completeness, consistency, and accuracy of medical records that support the physician’s judgment and medical decision making. Over the next 3 to 5 years, the CDI market is expected to witness major consolidation as merger and acquisition (M&A) activities increase among legacy EMR companies, CDI vendors, and legacy HIT vendors competing to provide pure-play solutions and capabilities on a centralized platform. The role of CDI in enabling healthcare equity will be paramount. Accurate, comprehensive, and ethnic-appropriate clinical documentation will help providers standardize reimbursement and opt for payment exceptions for specific population health management initiatives. This will allow equitable access to quality care for all. The impact of potential regulations centered around chronic condition management (e.g., COVID-19) focused on post-pandemic care, telemedicine, and virtual care will boost CDI growth further. Integrating CDI EMR workflow tools will help vendors offer more advanced CDI and best-in-class offerings and capabilities. Outsourcing CDI skills, training, and expertise will likely continue to rise, resulting in suboptimal outcomes and staff shortages. Author: Koustav Chatterjee
More Information
Deliverable Type Frost Radar
Author Koustav Chatterjee
GPS Codes 9564-B1,9600-B1,9612-B1
Industries Healthcare
No Index No
Is Prebook No
Podcast No
WIP Number K72F-01-00-00-00